Evidence map›Paper›PMID 36918278›Full record

ArticleLife science alliance2023

A novel approach to measure complex V ATP hydrolysis in frozen cell lysates and tissue homogenates.

Lucia Fernandez-Del-Rio, Cristiane Benincá, Frankie Villalobos, Cynthia Shu, Linsey Stiles, Marc Liesa, Ajit S Divakaruni, Rebeca Acin-Perez, Orian S Shirihai

Open access · goldFull text read
In one paragraph

Article in Life science alliance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Lucia Fernandez-Del-RioDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0001-5657-2700
Cristiane BenincáDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Frankie VillalobosDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Cynthia ShuDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0001-8215-2195
Linsey StilesDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Marc LiesaDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-5909-8570
Ajit S DivakaruniMetabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Rebeca Acin-PerezDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA rbkacin@gmail.com.ORCID https://orcid.org/0000-0001-9553-8337
Orian S ShirihaiDepartment of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA oshirihai@mednet.ucla.edu.ORCID https://orcid.org/0000-0001-8466-3431
University of California, Los Angeles · US

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
UCLA MSD ProgramR25GM055052 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARBER, PAUL HENRY, HASSON, TAMA W. · 1996 to 2021
$9.2M
Understanding How Metabolic Cofactors Control Cell Function and FateR35GM138003 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Ajit Divakaruni · 2020 to 2026
$2.8M
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMAR01CA232056 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI COLSON, YOLONDA L, GRINSTAFF, MARK W. · 2019 to 2023
$2.7M
Mitochondrial regulation of energy efficiencyR01DK099618 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CORKEY, BARBARA E., SHIRIHAI, ORIAN S · 2014 to 2018
$1.8M
Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver diseaseR01AA026914 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIRIHAI, ORIAN S · 2019 to 2022
$1.4M
R21: Acidic Nanoparticles for Restoration of Autophagy in Age-associated NAFLDR21AG063373 · NIA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GRINSTAFF, MARK W., SHIRIHAI, ORIAN S · 2019 to 2020
$458k
A novel approach for reversal of autophagic defects using lysosome-targeted nanoparticlesR21AG060456 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRINSTAFF, MARK W., SHIRIHAI, ORIAN S · 2019 to 2020
$455k
NCI NIH HHS R01 CA232056NIAAA NIH HHS R01 AA026914NIA NIH HHS R21 AG060456NIA NIH HHS R21 AG063373NIDDK NIH HHS P30 DK041301NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK099618NIGMS NIH HHS R25 GM055052NIGMS NIH HHS R35 GM138003
6 · The paper itself

Abstract

Mitochondrial depolarization can initiate reversal activity of ATP synthase, depleting ATP by its hydrolysis. We have recently shown that increased ATP hydrolysis contributes to ATP depletion leading to a maladaptation in mitochondrial disorders, where maximal hydrolytic capacity per CV content is increasing. However, despite its importance, ATP hydrolysis is not a commonly studied parameter because of the limitations of the currently available methods. Methods that measure CV hydrolytic activity indirectly require the isolation of mitochondria and involve the introduction of detergents, preventing their utilization in clinical studies or any high-throughput analyses. Here, we describe a novel approach to assess maximal ATP hydrolytic capacity and maximal respiratory capacity in a single assay in cell lysates, PBMCs, and tissue homogenates that were previously frozen. The methodology described here has the potential to be used in clinical samples to determine adaptive and maladaptive adjustments of CV function in diseases, with the added benefit of being able to use frozen samples in a high-throughput manner and to explore ATP hydrolysis as a drug target for disease treatment.

Indexed as

Adenosine TriphosphateMitochondrial Proton-Translocating ATPasesHydrolysisMitochondriaAdenosine TriphosphateMitochondrial Proton-Translocating ATPasesoligomycin sensitivity-conferring protein

Identifiers

PMID36918278
PMCPMC10019470
OpenAlexW4324133248

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read93
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.